Iridium Announces Release Date for Fourth-Quarter 2017 Financial Results
Feb 01, 2018 21:01 pm UTC| Business
MCLEAN, Va., Feb. 01, 2018 -- Iridium Communications Inc. (Nasdaq:IRDM) (“Iridium”) will host a conference call on Thursday, February 22, 2018 at 8:30 a.m. Eastern Time (ET) to discuss the Company’s fourth-quarter 2017...
Atossa Genetics Presents Additional Findings from its Phase 1 Study of Oral Endoxifen
Feb 01, 2018 21:01 pm UTC| Business
SEATTLE, Feb. 01, 2018 -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, today announced...
Women In Bio Announces Jane Wasman Appointed Chair of Sellas Life Sciences’ Board of Directors
Feb 01, 2018 21:01 pm UTC| Business
NEW YORK, Feb. 01, 2018 -- Women In Bio (WIB), an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life sciences, announced today the appointment of another...
Feb 01, 2018 21:01 pm UTC| Business
NEWARK, Calif., Feb. 01, 2018 -- CymaBay Therapeutics, Inc. (Nasdaq:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today...
athenahealth Reports Fourth Quarter and Full Year 2017 Results
Feb 01, 2018 21:01 pm UTC| Business
Q4 2017 Financial Results 14% Revenue Growth Over Fourth Quarter of 2016GAAP Operating Income of $38.7 million Non-GAAP Adjusted Operating Income of $77.6 millionGAAP Net Income of $31.6 million, or $0.78 Per Diluted...
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Feb 01, 2018 21:01 pm UTC| Business
BOSTON, Feb. 01, 2018 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, today...
Pacific Biosciences Announces Fourth Quarter and Annual 2017 Financial Results
Feb 01, 2018 21:00 pm UTC| Business
MENLO PARK, Calif., Feb. 01, 2018 -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced financial results for its fourth quarter and year ended December 31, 2017. Product, service and other...